Sugar Based Excipients Market: Information by Product (Actual Sugars, Sugar Alcohols, and Artificial Sweeteners), Type, Functionality, Formulation and Regional Outlook - Forecast Till 2026

Jun 03, 2019   Global Statistics Representing Sugar Based Excipients Market Scenario Pharmaceutical excipients play vital part in the drug delivery process. The main purpose of using excipients is to facilitate absorption of the drugs by a patient, provide substance to the formulation, and prevention from denaturation. In the drug manufacturing process, selecting an appropriate excipient is an important step to support the design of pharmaceutical formulation. A wide variety of excipients are used in the pha...
Request Free Sample Report

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Sugar Based Excipients Market

3.3       Key Market Trends

3.3.1    Drivers

3.3.2    Restraints

3.3.3    Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1    Bargaining Power of Suppliers

3.4.2    Bargaining Power of Buyers

3.4.3    Threat of Substitution

3.4.4    Threat of New Entrants

3.4.5    Competitive Rivalry

3.5       Market Share Analysis

4          Product Overview

4.1       Introduction

4.1.1    Market Size & Forecast

4.2       Actual Sugars

4.3       Sugar Alcohols

4.4       Artificial Sweeteners

5          Type Overview

5.1       Introduction

5.1.1    Market Size & Forecast

5.2       Powders/Granules

5.3       Direct Compression Sugars

5.4       Crystals

5.5       Syrups

6          Functionality Overview

6.1       Introduction

6.1.1    Market Size & Forecast

6.2       Fillers & Diluents

6.3       Flavoring Agents

6.4       Tonicity Agents

6.5       Other Functionalities

7          Functionality Overview

7.1       Introduction

7.1.1    Market Size & Forecast

7.2       Oral Formulations

7.3       Parenteral Formulations

7.4       Topical Formulations

7.5       Other Formulations

8          Regional Overview

8.1       Introduction

8.1.1    Market Size & Forecast

8.2       America

8.2.1    North America

8.2.1.1 U.S.

8.2.1.1.1          By Type

8.2.1.1.2          By Product

8.2.1.1.3          By Formulation

8.2.1.1.4          By Functionality

8.2.1.2 Canada

8.2.1.2.1          By Type

8.2.1.2.2          By Product

8.2.1.2.3          By Formulation

8.2.1.2.4          By Functionality

8.2.1.3 Mexico

8.2.1.3.1          By Type

8.2.1.3.2          By Product

8.2.1.3.3          By Formulation

8.2.1.3.4          By Functionality

8.2.2    South America

8.2.2.1 By Type

8.2.2.2 By Functionality

8.3       Europe

8.3.1    Market Size & Forecast

8.3.2    Germany

8.3.2.1 By Type

8.3.2.2 By Product

8.3.2.3 By Formulation

8.3.2.4 By Functionality

8.3.3    France

8.3.3.1 By Type

8.3.3.2 By Product

8.3.3.3 By Formulation

8.3.3.4 By Functionality

8.3.4    U.K.

8.3.4.1 By Type

8.3.4.2 By Product

8.3.4.3 By Formulation

8.3.4.4 By Functionality

8.3.5    Italy

8.3.5.1 By Type

8.3.5.2 By Product

8.3.5.3 By Formulation

8.3.5.4 By Functionality

8.3.6    Spain

8.3.6.1 By Type

8.3.6.2 By Product

8.3.6.3 By Formulation

8.3.6.4 By Functionality

8.3.7    Rest of Europe

8.3.7.1 By Type

8.3.7.2 By Product

8.3.7.3 By Formulation

8.3.7.4 By Functionality

8.4       Asia Pacific

8.4.1    Market Size & Forecast

8.4.2    Japan

8.4.2.1 By Type

8.3.2.2 By Product

8.3.2.3 By Formulation

8.4.2.4 By Functionality

8.4.3    China

8.4.3.1 By Type

8.4.3.2 By Product

8.4.3.3 By Formulation

8.4.3.4 By Functionality

8.4.4    Australia

8.4.4.1 By Type

8.4.4.2 By Product

8.4.4.3 By Formulation

8.4.4.4 By Functionality

8.4.5    India

8.4.5.1 By Type

8.4.5.2 By Product

8.4.5.3 By Formulation

8.4.5.4 By Functionality

8.4.6    South Korea

8.4.6.1 By Type

8.4.6.2 By Product

8.4.6.3 By Formulation

8.4.6.4 By Functionality

8.4.7    Rest of Asia-Pacific

8.4.7.1 By Type

8.4.7.2 By Product

8.4.7.3 By Formulation

8.4.7.4 By Functionality

8.5       Middle East & Africa

8.5.1    Market Size & Forecast

8.5.2    Saudi Arabia

8.5.2.1 By Type

8.5.2.2 By Product

8.5.2.3 By Formulation

8.5.2.4 By Functionality

8.5.3    South Africa

8.5.3.1 By Type

8.5.3.2 By Product

8.5.3.3 By Formulation

8.5.3.4 By Functionality

8.5.4    Kuwait

8.5.4.1 By Type

8.5.4.2 By Product

8.5.4.3 By Formulation

8.5.4.4 By Functionality

8.5.5    Rest of Middle East & Africa

8.5.5.1 By Type

8.5.5.2 By Product

8.5.5.3 By Formulation

8.5.5.4 By Functionality

9          Company Profile

9.1       Archer Daniels Midland Company

9.1.1    Company Overview

9.1.2    Financial Performance

9.1.3    Recent Developments

9.1.4    Product Portfolio

9.2       Meggle AG

9.2.1    Company Overview

9.2.2    Financial Performance

9.2.3    Recent Developments

9.2.4    Product Portfolio

9.3       Ashland Inc

9.3.1    Company Overview

9.3.2    Financial Performance

9.3.3    Recent Developments

9.3.4    Product Portfolio

9.4       The Lubrizol Corporation

9.4.1    Company Overview

9.4.2    Financial Performance

9.4.3    Recent Developments

9.4.4    Product Portfolio

9.5       Roquette Group

9.5.1    Company Overview

9.5.2    Financial Performance

9.5.3    Recent Developments

9.5.4    Product Portfolio

9.6       DFE Pharma

9.6.1    Company Overview

9.6.2    Financial Performance

9.6.3    Recent Developments

9.6.4    Product Portfolio

9.9       Cargill

9.7.1    Company Overview

9.7.2    Financial Performance

9.7.3    Recent Developments

9.7.4    Product Portfolio

9.8       Associated British Foods PLC

9.8.1    Company Overview

9.8.2    Financial Performance

9.8.3    Recent Developments

9.8.4    Product Portfolio

9.9       Colorcon Inc.

9.9.1    Company Overview

9.9.2    Financial Performance

9.9.3    Recent Developments

9.9.4    Product Portfolio

9.10     FMC Corporation

9.10.1  Company Overview

9.10.2  Financial Performance

9.10.3  Recent Developments

9.10.4  Product Portfolio